JASCO has more than 55 years of experience within the academic, pharmaceutical, forensics, biotechnology, and industrial markets worldwide. JASCO's line of spectroscopy instrumentation includes FT-IR and microscopy, portable FT-IR, Raman, portable Raman, UV-vis, NIR, fluorescence, circular dichroism, polarimetry, ellipsometry, near-field and dissolution testing. In addition, JASCO specializes in a full line of HPLC and SFC/SFE instrumentation. For more information, please visit www.jascoinc.com.
Our spectroscopy products are found in a wide variety of industries including academic, pharmaceutical, forensics, biotechnology, chemical, fuel, and industrial customer labs.
The major products manufactured by JASCO Corporation include molecular spectroscopy instrumentation for all manner of applications. JASCO specializes in circular dichroism (CD) and FT-IR, as well as Raman, UV-vis, fluorescence, polarimeters, ellipsometers and scanning near-field microscopy (NSOM). We offer applications support and method development to our customers for all molecular spectroscopy products.
While our products are manufactured in Japan, we have offices worldwide including our main US office in Maryland with a complete demonstration and sample analysis lab. We also have a demonstration lab in Southern California.
JASCO
28600 Mary's Court
Easton, MD 21601
TELEPHONE
(800) 333-5272
FAX
(410) 822-7526
E-MAILsales@jascoinc.com
WEB SITEwww.jascoinc.com
NUMBER OF US EMPLOYEES
50
EMPLOYEES OUTSIDE US
500
YEAR FOUNDED
1958
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.